- €727.60m
- €490.82m
- €584.76m
- 62
- 14
- 62
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 701 | 528 | 507 | 536 | 585 |
Cost of Revenue | |||||
Gross Profit | 519 | 423 | 407 | 450 | 496 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 932 | 813 | 600 | 634 | 605 |
Operating Profit | -231 | -285 | -93.2 | -97.6 | -20 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -234 | -295 | -86.9 | -94.8 | -14 |
Provision for Income Taxes | |||||
Net Income After Taxes | -193 | -258 | -94.7 | -103 | -21 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 633 | -258 | -94.7 | -103 | -21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 633 | -258 | -94.7 | -103 | -21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.11 | -1.97 | -0.738 | -0.671 | -0.123 |
Dividends per Share |